SN.L - Smith & Nephew plc
| Previous close | 1,733.00 |
| Open | 1,728.50 |
| Bid | 1,749.50 x 0 |
| Ask | 1,749.50 x 0 |
| Day's range | 1,728.50 - 1,751.00 |
| 52-week range | 1,242.50 - 1,772.00 |
| Volume | 186,990 |
| Avg. volume | 2,230,811 |
| Market cap | 15.3B |
| Beta (3Y monthly) | 0.32 |
| PE ratio (TTM) | 23.10 |
| EPS (TTM) | 75.70 |
| Earnings date | 31 Jul 2019 |
| Forward dividend & yield | 0.28 (1.59%) |
| Ex-dividend date | 2019-04-04 |
| 1y target est | 18.49 |
- Simply Wall St.•7 days ago
Will Smith & Nephew plc's (LON:SN.) Earnings Grow Over The Next Year?
Looking at Smith & Nephew plc's (LON:SN.) earnings update in December 2018, it seems that analyst forecasts are fairly...
- Simply Wall St.•22 days ago
Despite Its High P/E Ratio, Is Smith & Nephew plc (LON:SN.) Still Undervalued?
This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios...
- Simply Wall St.•22 days ago
Estimating The Intrinsic Value Of Smith & Nephew plc (LON:SN.)
Does the June share price for Smith & Nephew plc (LON:SN.) reflect what it's really worth? Today, we will estimate the...
- Fool.co.uk•27 days ago
These FTSE 100 stocks have been on a tear. Can the good times continue?
Paul Summers takes a look at three FTSE 100 (LON:INDEXFTSE:UKX) that have been sprinting away from the pack.
- Simply Wall St.•last month
Need To Know: Smith & Nephew plc (LON:SN.) Insiders Have Been Selling Shares
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
- Fool.co.uk•last month
Forget buy-to-let: I think these 2 FTSE 100 shares can help you become an ISA millionaire
These two FTSE 100 (INDEXFTSE:UKX) stocks appear to offer improving prospects that I think could boost your ISA returns.
- Simply Wall St.•2 months ago
Do Directors Own Smith & Nephew plc (LON:SN.) Shares?
A look at the shareholders of Smith & Nephew plc (LON:SN.) can tell us which group is most powerful. Insiders often...
- Fool.co.uk•2 months ago
Forget a Cash ISA! I’d buy these 3 FTSE 100 dividend growth stocks right now
I’d make these three FTSE 100 (INDEXFTSE: UKX) stalwarts core holdings in my portfolio.
- Simply Wall St.•2 months ago
How Good Is Smith & Nephew plc (LON:SN.), When It Comes To ROE?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
- Business Wire•2 months ago
New NICE guidance recognises that Smith & Nephew’s PICO™ sNPWT provides better outcomes than standard dressings in patients at high risk of surgical site infections, at similar overall cost
Smith & Nephew , the global medical technology business, welcomes the launch of new medical technologies guidance from the UK National Institute for Health and Care Excellence .
- Reuters•3 months ago
Smith & Nephew lifts revenue view after best quarter since 2015
Emerging markets, especially China, have been a bright spot for the company as its mature markets, including the United States which accounts for about half of its revenue, stabilise after a shaky start to last year. Growth of 15.3 percent in emerging markets powered Smith & Nephew's total revenue to $1.20 billion (£919.4 million), in line with analysts' expectations, according to a company-compiled consensus http://www.smith-nephew.com/investor-centre/reporting/analyst-consensus. Demand from emerging markets will continue to lift the company as patient populations grow and medical expertise improves, Chief Executive Officer Namal Nawana told Reuters.
- Simply Wall St.•3 months ago
Why Fundamental Investors Might Love Smith & Nephew plc (LON:SN.)
Attractive stocks have exceptional fundamentals. In the case of Smith & Nephew plc (LON:SN.), there's is a notable dividend-paying company that has been able to sustain great financial health over t...
- Simply Wall St.•3 months ago
How Good Is Smith & Nephew plc (LON:SN.) At Creating Shareholder Value?
Today we'll look at Smith & Nephew plc (LON:SN.) and reflect on its potential as an investment. Specifically, we're going to calculate its Return On Capital Employed (ROCE), in the hopes of getting some insight into the business. F...
- Simply Wall St.•4 months ago
How Much Money Does Smith & Nephew plc (LON:SN.) Make?
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! If you are currently a shareholder in Smith & Nephew plc (LON:SN.), or considering investing in the stock, you need to examin...
Reuters•4 months agoEU competition head unlikely to rule on UK tax probe this month
By Foo Yun Chee and Klaus Lauer BERLIN (Reuters) - European Union regulators are unlikely to rule by the end of March on whether a UK tax scheme for multinationals breaches EU rules on state aid, Europe's ...
- Simply Wall St.•4 months ago
Investors Who Bought Smith & Nephew (LON:SN.) Shares Five Years Ago Are Now Up 57%
When we invest, we're generally looking for stocks that outperform the market average. And while active stock picking involves risks (and requires diversification) it can also provide excess returns. ForRead More...
- Reuters - UK Focus•4 months ago
BUZZ-NuVasive: Tumbling as Smith & Nephew strikes Osiris deal
** NuVasive shares tumble 7.2 pct to $54.48 in Tues morning trading, on pace for biggest one-day percentage drop in two months ** Medical device co's share drop comes as British medical products maker ...
- Reuters•4 months ago
Smith & Nephew to buy Osiris in regenerative products push
The deal will help Smith & Nephew better compete with bigger rivals such as U.S.-based Johnson & Johnson as Osiris's products, including skin and bone grafts, complements its portfolio of wound care products. "Greater presence in the fast growing regenerative medicine market enhances our portfolio and will help immediately accelerate our wound management business," Smith & Nephew Chief Executive Officer Namal Nawana said.
- Reuters - UK Focus•5 months ago
FTSE 100 climbs as U.S.-China trade talks take off
British blue-chip names bounced back on Monday buoyed by strength in bank and consumer shares, while a stronger dollar lifted companies with greater international exposure as a fresh round of Sino-U.S. ...
Reuters•5 months agoEuropean shares bounce back as trade talks resume
European shares bounced back on Monday as new-found optimism among investors about the new round of trade talks between Beijing and Washington lifted bourses from one-week lows. Analysts cautioned that sentiment about the trade talks was volatile and that a favourable outcome was by no means a done deal. "As U.S.–Sino trade talks begin in Beijing we are once again seeing the markets adopt an all too familiar optimistic stance", wrote market City Index analyst Fiona Cincotta.
